Craniosacral Therapy Children's, Balance-Coordination
CS-CHILDREN
Craniosacral Therapy as a Neurodevelopmental Correction for the Improvement of Children's Balance and Coordination.
1 other identifier
interventional
86
1 country
1
Brief Summary
Coordination and balance are manifested as motor skills or abilities that are acquired as the Central Nervous System develops. In the infant stage, these qualities help guide specialists to recognize possible abnormalities that at first glance seem banal, but that, as time goes by, acquire greater difficulty, causing even more complex problems in the long term. Craniosacral therapy could help these skills to be correctly established during growth, correcting such impairment in time during neurodevelopment. Objective: To correct possible alterations that occur during infant growth related to balance and coordination in neurodevelopment, by means of craniosacral therapy compared with the specific therapy of balance and coordination usually used in pathologies diagnosed of this caliber. Design: Longitudinal-experimental study with a population of 86 apparently healthy children. Setting/Participants: 86 children were treated without excluding sex and divided into three groups: placebo group (n=25), craniosacral therapy group (n=30) and balance and coordination therapy group (n=31). Interventions: group 1 (placebo), group 2 (craniosacral therapy) group 3 (balance and coordination therapy). Results: The Battelle scale prior to the therapies developed in the study showed balance and coordination imbalances in the participants of the three groups, with lower percentages in the placebo treatment. Sessions from the 2nd to the 7th of treatment show increasing percentages and fluctuating for craniosacral therapy between 51% to 56% and 100% satisfaction, significantly valued. As for balance and coordination therapy, satisfaction percentages are evident only in the 6th and 7th sessions, with statistically significant values. Finally, the Battelle post-therapy assessment scale shows a higher number of participants in the percentages classified as normal (50-80%) in the craniosacral therapy group, improving the evaluated parameters with statistically significant values. Conclusion: The study shows that craniosacral therapy can not only act as a treatment for the improvement of children's balance and coordination, but also helps small corrections during children's neurodevelopment, avoiding the evolution of pathologies in the long term. It is therefore necessary for a more prompt, total and lasting correction of these skills in the infant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2021
CompletedFirst Submitted
Initial submission to the registry
August 7, 2021
CompletedFirst Posted
Study publicly available on registry
August 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 17, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2021
CompletedDecember 29, 2021
December 1, 2021
3 months
August 7, 2021
December 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
"Series of questions to the children's parents"
A series of questions were asked to the children's parents in a virtual questionnaire on physical characteristics, previous health assessments and observations of their balance and coordination in front of their children
two weeks
"Battelle Developmental Inventory" (BDI)
On the other hand, the school teachers examined neurobehavioral aspects of the students using the "Battelle Developmental Inventory" (BDI), which evaluates five areas of development (personal/social, adaptive, motor, communicative and cognitive) between 2 and 8 years of age. The results are assigned in age-adjusted percentages, classified as: low (0-49%), normal (50-79%) and high (80-100%). Low and high values are considered impairments in one or more of the areas evaluated
two weeks
Secondary Outcomes (5)
"Number of participants in each therapy group"
Seven weeks
"The effectiveness values of the therapies for each group"
seven weeks
"Pre-treatment Battelle Scale"
two weeks
"Post-treatment Battelle Scale"
two weeks
"percentages of satisfaction from 1st to the 7th therapy sessions"
seven weeks
Study Arms (3)
Patients receiving craniosacral therapy
EXPERIMENTAL30 children without previous pathology receiving craniosacral therapy
Patients receiving balance and coordination therapy
ACTIVE COMPARATOR31 patients without previous pathology receiving balance and coordination therapy
Patients receiving placebo
PLACEBO COMPARATOR25 patients without previous pathology receiving placebo
Interventions
A series of questions were asked to the children's parents in a virtual questionnaire on physical characteristics, previous health assessments and observations of their balance and coordination in front of their children
the school teachers examined neurobehavioral aspects of the students using the "Battelle Developmental Inventory" (BDI), which evaluates five areas of development (personal/social, adaptive, motor, communicative and cognitive) between 2 and 8 years of age. The results are assigned in age-adjusted percentages, classified as: low (0-49%), normal (50-79%) and high (80-100%). Low and high values are considered impairments in one or more of the areas evaluated. Evaluation of the Battelle scale was carried out before and after the therapy sessions.
Seven treatment sessions were carried out with the balance and coordination therapeutic exercise techniques (group 3) most frequently used for the treatment of these pathologies; seven sessions of craniosacral therapy (group 2) as corrective and preventive in possible alterations during infant neurodevelopment and finally seven sessions simulating craniosacral therapy on a placebo group (group 1) as a control of the treatments used.
Eligibility Criteria
You may qualify if:
- healthy children
- aged 6 to 8 years old
- school group
You may not qualify if:
- unhealthy children
- ages outside the 6-8 age range
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gema León Physiotherapy and Rehabilitation Clinic
Córdoba, Andalusia, 14011, Spain
Study Officials
- STUDY CHAIR
Irene Cantarero Carmona
Universidad de Córdoba
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Patients will not know whether they will be treated or given a placebo.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 7, 2021
First Posted
August 12, 2021
Study Start
August 1, 2021
Primary Completion
October 17, 2021
Study Completion
December 28, 2021
Last Updated
December 29, 2021
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share
The request for the data will be studied and considered upon prior and justified request.